Mohammad Afaque Alam, PhD, Associate Scientist in the Sol Sherry Thrombosis Research Center at the Lewis Katz School of Medicine at Temple University, was the first author of the research team that used a mouse model of hyperoxia-induced lung injury and bronchopulmonary dysplasia patients to investigate the expression profile and functional role of microRNA199a-5p after hyperoxia. The team’s study results indicate that miR199a-5p inhibitors might be a new therapeutic option for improving bronchopulmonary dysplasia in preterm newborns. The findings were selected to be highlighted in the “Editor’s Focus” of November’s Pediatric Research.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Becker’s ASC Review Highlights Healthgrades Ranking Temple University Hospital among Best Hospitals in U.S. for Cardiac Surgery
Posted April 8, 2024The rankings recognize hospitals that deliver superior patient outcomes in heart bypass surgery and heart valve surgery.
Read MoreTemple Health’s Excellence in Health Equity: CBS3 Segment on Peripartum Cardiomyopathy Featuring Dr. Deborah Crabbe, Patient and Son is Picked up by Dozens of TV Stations Across the Country
Posted April 3, 2024A CBS3 segment on peripartum cardiomyopathy featured Deborah L. Crabbe, MD, FACC, FAHA, Professor of Medicine at the Lewis Katz School of Medicine at Temple University; patient Chelsi Svenson-Boyce; and her son Jaxson. The segment was picked up by dozens of stations across the country.
Read More